Patient recruitment has long been a bottleneck in clinical trials, especially in inflammatory bowel disease (IBD), where competition for eligible participants is fierce. In a game-changing collaboration, Thermo Fisher’s PPD clinical research business and Virgo are leveraging real-time endoscopy video data and AI-powered tools to identify trial candidates during routine diagnostic procedures.
Virgo’s platform, already deployed in 150+ sites, captures and analyzes endoscopic video to match patients to appropriate IBD trials at the moment of diagnosis — eliminating the need for repeat procedures and drastically shortening recruitment timelines. With over 1.7 million procedures recorded and proprietary AI like AutoIBD, Virgo is redefining how trials meet patients where they are — in real time, at the point of care.